A carregar...
Two‐year effectiveness and safety of golimumab in ulcerative colitis: An IG‐IBD study
BACKGROUND: Few data exist regarding the long‐term effectiveness of golimumab in ulcerative colitis. No data have been reported on real‐world continuous clinical response. OBJECTIVE: This study aimed to describe the long‐term outcomes in a large cohort of patients on golimumab who had ulcerative col...
Na minha lista:
| Publicado no: | United European Gastroenterol J |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8259241/ https://ncbi.nlm.nih.gov/pubmed/33203342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640620974308 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|